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Hereditary hearing loss (HHL) is a very common
disorder. When inherited in an autosomal reces-
sive manner, it typically presents as an isolated
finding. Interestingly and unexpectedly, in spite
of extreme heterogeneity, mutations in one gene,
GJB2, are the most common cause of congenital
severe-to-profound deafness in many different
populations. In this study, we assessed the con-
tributions made by GJB2 mutations and chromo-
some 13 g.1777179_2085947del (the deletion more
commonly known as del (GJB6-D13S1830) that
includes a portion of GJB6 and is hereafter called
D(GJB6-D13S1830)) to the autosomal recessive
non-syndromic deafness (ARNSD) genetic load in
Iran. Probands from 664 different nuclear fami-
lies were investigated.GJB2-related deafness was
found in 111 families (16.7%). The carrier fre-
quency of the 35delG mutation showed a geo-
graphic variation that is supported by studies in
neighboring countries. D(GJB6-D13S1830) was
not found. Our prevalence data for GJB2-related
deafness reveal a geographic pattern that mirrors
the south-to-north European gradient and sup-
ports a founder effect in southeastern Europe.
 2005 Wiley-Liss, Inc.
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INTRODUCTION
Hearing loss is the most common sensory defect in humans.
One in 1,000 babies is born with severe-to-profound deafness,
and some degree of hearing loss impacts normal communica-
tion in 4% of people younger than age 45 years and 10% of
people aged 65 years or older [Morton, 1991; Gorlin et al., 1995;
Petit, 1996]. Etiology is multifactorial and includes genetic and
environmental factors. Estimates suggest that half of pre-
lingual non-syndromic deafness is inherited, and in more than
80% of these cases, the mode of transmission is autosomal
recessive [Morton, 1991; Marazita et al., 1993; Gorlin et al.,
1995].
In many different populations, mutations in one gene,GJB2,
are the most important cause of prelingual non-syndromic
deafness [Chaib et al., 1994; Maw et al., 1995; Carrasquillo
et al., 1997; Denoyelle et al., 1997; Kelsell et al., 1997; Van
Camp et al., 1997; Zelante et al., 1997; Morell et al., 1998; Park
et al., 2000]. In persons of northern European extraction, one
allele variant of GJB2 predominates—the 35delG mutation
[Denoyelle et al., 1997; Kelley et al., 1998; Lench et al., 1998;
Green et al., 1999; Gasparini et al., 2000; Lucotte and Mercier,
2001]. This mutation is followed closely by D(GJB6-
D13S1830) in several populations such as the Spanish [Del
Castillo et al., 2002, 2003]. In this study, we assessed the
frequency of GJB2 mutations and D(GJB6-D13S1830) in the
Iranian population. GJB2 and GJB6 encode connexin 26 and
connexin 30, respectively.
MATERIALS AND METHODS
Patients
Probands segregating presumed autosomal recessive non-
syndromic deafness (ARNSD) were eligible for inclusion in this
study if they met the following inclusion criteria: (1) audiologic
testing to confirm hearing loss; (2) absence of other abnormal
clinical features that would be consistent with syndromic
hearing loss; (3) presence of at least one other family member
with hearing loss; (4) an inheritance pattern consistent with
autosomal recessive transmission. On consenting persons,
audiometric testing and physical examinations were com-
pleted, followed by venipuncture to obtain 10 ccs of whole blood
as a DNA source. Human Research Institutional Review
Boards at the Welfare Science and Rehabilitation University
and the Iran University of Medical Sciences, Tehran, Iran, and
the University of Iowa, Iowa City, IA approved all procedures.
Genetic Testing
Genetic testing was completed using a tiered approach. The
first step was an allele-specific polymerase chain reaction
(ASPCR) assay to screen all study participants for the 35delG
mutation using previously described primers [Scott et al.,
1998a]. No further testing was done on persons homozygous for
the 35delG allele variant of GJB2, and in this group, the
diagnosis of DFNB1 deafness was made.
In 35delG heterozygotes, DHPLC analysis of the coding
sequence of GJB2 (exon 2) was completed and complemented
by direct sequencing if elution profiles were not consistent with
the 35delG heterozygote state. Persons were diagnosed with
DFNB1 deafness if a second deafness-causing GJB2 allele
variant was identified in exon 2. In samples in which the
elution profile was consistent with only the 35delG carrier
state, the non-coding exon ofGJB2 (exon 1) was sequenced and
a PCR-based assay was used to screen for D(GJB6-D13S1830),
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as previously described [Del Castillo et al., 2002]. If either of
these other mutations was identified, the diagnosis of DFNB1
deafness was made.
DHPLC screening of exon 2 of GJB2 was also completed in
all persons in whom the 35delG mutation was not detected
by the ASPCR. If abnormal elution profiles were observed,
the sample was sequenced, and if two deafness-causing allele
variants of GJB2 were identified, the diagnosis of DFNB1 was
made. If only a single deafness-causing allele variant of GJB2
was identified, we screened the non-coding exon of GJB2 and
for D(GJB6-D13S1830), as described above [Del Castillo et al.,
2003]. The finding of either of these mutations together with a
deafness-causing allele variant of exon 2 ofGJB2 rendered the
diagnosis of DFNB1.
Lastly, we randomly selected and screened 115 study parti-
cipants who carried two normal GJB2 alleles for D(GJB6-
D13S1830).
RESULTS
Patients
Probands from 664 families participated in this study. Study
participants were ascertained throughout Iran, which we
divided into eight regions based on geographic and racial
identity (Table I, Fig. 1). We also completed mutation screening
in 35 simplex cases of deafness. Since there were no other deaf
persons in these 35 families, the possibility of acquired con-
genital deafness could not be excluded.
Genetic Testing
In total, 111 of 664 probands (16.7%) were found to have
GJB2 deafness-causing allele variants and were diagnosed
with DFNB1 deafness. In northwest and west Iran, where a
Fig. 1. Iran had been divided into eight regions based on geographic and
ethnic considerations (Northwest-West Azerbaijan, East Azerbaijan,
Ardebil, and Zanjan; North-Gilan, Mazandaran, and Golestan; Northeast-
Khorasan; West-Kordestan, Hamedan, Kermanshah, Lorestan, and Ilam;
Central-Tehran, Qazvin, Markazi, Qom, Semnan, Esfahan, and Yazd;
Southwest-Khoozestan, Charmahaal, Kohkilooyeh, and Fars; South-
Booshehr, and Hormazgan; Southeast-Kerman, Sistan and Baloochestan).
Percentages show the frequency of GJB2-related deafness.
TABLE II. GJB2 Deafness Genotypes Based on Geographic Regions
Genotypes NW W SW N C S NE SE Iran
310del14/310del14 —- — — — 1 — — — 1
35delG/35delG 14 16 7 15 16 — 1 1 70
W24X/W24X — — — — 1 — — 3 4
delE120/delE120 — 1 — — 1 — — 1 3
314del14/314del14 — 1 — — 1 — — — 2
167delT/R184P — — — — — — 1 — 1
R184P/3170G>A — — — — — — 1 — 1
35delG/3170G>A 3 3 — 2 2 — 1 — 11
35delG/R143W — — — — — — — 1 1
35delG/W24X 1 1 — — — — — — 2
35delG/R32H — — — — 1 — — — 1
35delG/delE120 1 1 — — — — — — 2
R32H/R32H — 1 — — 1 — — — 2
35delG/IVS1þ1G>A — 2 — — — — — — 2
R184P/IVS1þ1G>A — 1 — — — — — — 1
W24X/3170G>A — — — 1 — — — — 1
312del14/312del14 — — — — 2 — — — 2
167delT/167delT — — — — — — — 1 1
R127H/R127H — — — — — — — 2 2
Q80L/Q80L 1 — — — — — — — 1
Total 20 27 7 18 26 0 4 9 111
TABLE I. Proband Ascertainment by Geographic Region
Geographic region Probands GJB2-related deafness
Northwest 90 20 (22.2%)
West 172 27 (15.7%)
Southwest 46 7 (15.2%)
North 47 18 (38.3%)
Central 170 26 (15.3%)
South 10 0
Northeast 31 4 (13%)
Southeast 98 9 (9.2%)
Total 664 111 (16.7%)
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relation with other Turk populations exists, we found that
22.2% and 15.7% of probands, respectively, had GJB2-related
deafness. In north Iran, the percentage of GJB2-related
deafness was even higher at 38.3%, while in the south and
southeast, it was lower (Table I, Fig. 1).
Genotypes related to GJB2-related deafness are listed in
Table II. The most frequent genotype, homozygosity for the
35delG mutation, accounted for 63.1% of GJB2-related deaf-
ness. Next in frequency was compound heterozygosity for
the 35delG mutation and a splice site mutation in exon 1
(3170G>A), which was found throughout the northern and
west regions of Iran. We found two novel mutations, 363delC
and Q80L, in a 35delG/363delC compound heterozygote and a
Q80L homozygote. Two probands with R127H/V153I were
identified from southeast and west Iran.
GJB2 allele variants are shown in Table III. In addition to
the 363delC and Q80L, we identified two other novel deafness-
causing mutations, 507insAACG and 329delA, although in
the carriers of these two mutations a second mutation in the
DFNB1 interval was not identified (507insAACG, west Iran;
363delC and Q80L, northwest Iran; 329delA, central Iran). The
most frequent benign polymorphism was V153I, which was
carried by nine persons. A single I69I synonymous mutation
was identified in a person from central Iran and a V52V
synonymous mutation was found in an Arab proband from
southwestern Iran. Carrier frequencies for severalGJB2 allele
variants among the 553 probands in whom a diagnosis of
DFNB1 deafness could not be made (664–111) are shown in
Table IV.
Of the simplex cases, three (8.6%) hadDFNB1 deafness, and
of the remaining 32 persons one (3.1%) was a 35delG carrier.
This figure is not significantly different from the 1.3% 35delG
carrier rate found in the 553 deaf probands with presumed
ARNSD (P¼ 0.389), and is similar to that reported in an earlier
study on this population (Table V) [Najmabadi et al., 2002].
None of patients screened forD(GJB6-D13S1830) was shown
to carry this deletion.
DISCUSSION
Deafness at the DFNB1 locus is the most common cause of
ARNSD in many countries throughout the world [Zelante
et al., 1997; Estivill et al., 1998; Kelley et al., 1998; Morell et al.,
1998; Scott et al., 1998]. Typically caused by mutations in
TABLE III. GJB2 Allele Variants by Geographic Regions
Allele variant Iran Northwest West Southwest North Central South Northeast Southeast
Mutation
delE120 13 (1%) 3 (1.6%) 5 (1.4%) — — 3 (0.9%) — — 2 (1.02%)
167delT 3 (0.2%) — — — — — — 1 (1.6%) 2 (1.02%)
R184P 3 (0.2%) — 1 (0.3%) — — — — 2 (3.2%) —
310del14 2 (0.15%) — — — — 2 (0.6%) — — —
V27IþE114G 3 (0.2%) — — 1 (1.1%) — 2 (0.6%) — — —
R32H 5 (0.37%) — 2 (0.6%) — — 3 (0.9%) — — —
314del14 4 (0.3%) — 2 (0.6%) — — 2 (0.6%) — — —
35delG 167 (12.6%) 35 (19.4%) 42 (12.2%) 15 (16.3%) 32 (34%) 37 (11%) — 3 (4.8%) 3 (1.5%)
IVS1þ1G>A 3 (0.2%) — 3 (0.9%) — — — — — —
3170G>A 13 (1%) 3 (1.6%) 3 (0.9%) — 3 (3.2%) 2 (0.6%) — 2 (3.2%) —
R127H 11 (0.8%) — 3 (0.9%) — 1 (1.1%) 1 (0.3%) — — 6 (3.1%)
W24X 11 (0.8%) 1 (0.5%) 1 (0.3%) — 1 (1.1%) 2 (0.6%) — — 6 (3.1%)
R143W 1 (0.07%) — — — — — — — 1 (0.51%)
E129K 1 (0.07%) 1 (0.5%) — — — — — — —
312del14 4 (0.3%) — — — — 4 (1.2%) — — —
M93I 1 (0.07%) — — — — — — — 1 (0.51%)
Novel
507insAACG 1 (0.07%) — 1 (0.3%) — — — — — —
329delA 1 (0.07%) — — — — 1 (0.3%) — — —
363delC 1 (0.07%) 1 (0.5%) — — — — — — —
Q80L 2 (0.15%) 2 (1%) — — — — — — —
Polymorphism
V153I 36 (2.7%) 2 (1%) 12 (3.5%) 6 (6.5%) 4 (4.2%) 2 (0.6%) — 1 (1.6%) 9 (4.6%)
V27I 9 (0.7%) 3 (1.6%) 3 (0.9%) — — 2 (0.6%) — 1 (1.6%) —
V52V — — — 1 (1.1%) — — — — —
I69I 1 (0.07%) — — — — 1 (0.3%) — — —
Total alleles tested 1,328 180 344 92 94 340 20 62 196
TABLE IV. Carrier Frequencies for Selected GJB2 Allele
Variants Among the 553 Deaf Probands in Whom DFNB1
Deafness Could not be Diagnosed
Genotypes Frequency
35delG/wt 1.05% (7)
delE120/wt 0.9% (5)
R127H/wt 0.7% (4)
V27IþE114G/wt 0.2% (1)
507insAACG/wt 0.2% (1)
E129K/wt 0.2% (1)
M93I/wt 0.2% (1)
TABLE V. GJB2 Genotypes in 35 Simplex Cases
of Congenital Deafness
Genotype Frequency Etiology of deafness
wt/wt 27 (77%) Unknown
V153I/wt 2 (5.7%) Unknown
35delG/35delG 1 (2.85%) DFNB1 deafness
35delG/delE120 1 (2.85%) DFNB1 deafness
35delG/K112Na 1 (2.85%) DFNB1 deafness
35delG/wt 1 (2.85%) Unknown
V27IþE114G/wt 1 (2.85%) Unknown
V27I/wt 1 (2.85%) Unknown
aK112N, novel allele variant.
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GJB2, the deafness is characteristically congenital and stable,
varying in severity from moderate to profound [Morton, 1991;
Gorlin et al., 1995; Petit, 1996]. One GJB2 mutation, the
35delG allele variant, is most common in populations of
northern European ancestry. The carrier rate for this mutation
among Caucasian people ranges from 1% to 3% [Kelley et al.,
1998]. In other racial groups, other GJB2 mutations are more
common, as for example, 167delT among Ashkenazi Jews and
R143W in Africans [Brobby et al., 1998; Morell et al., 1998;
Lerer et al., 2000; Park et al., 2000; Sobe et al., 2000;
Hamelmann et al., 2001; Shahin et al., 2002].
D(GJB6-D13S1830), a deletion of approximately 309 kb
with one breakpoint inside the GJB6 coding region, also
causes deafness at the DFNB1 locus [Del Castillo et al.,
2002; Stevenson et al., 2003; Erbe et al., 2004]. In a re-
cent multinational study, analyzing data from nine countries,
D(GJB6-D13S1830) was shown to account for 5.9%–9.7% of all
DFNB1 alleles in Spain, France, the United Kingdom, Israel,
and Brazil. Lower frequencies were found in Belgium and
Australia (1.3%–1.4%) [Del Castillo et al., 2003]. Although the
frequency of D(GJB6-D13S1830) in these populations was not
high enough to result in a large number of homozygous
patients, the authors recommend that genetic testing for
deafness at the DFNB1 locus include screening for D(GJB6-
D13S1830).
In this study, the 35delG mutation was the most common
deafness-causing allele variant of GJB2 we identified, occur-
ring in 71.6% of persons with DFNB1 deafness. Since the
Iranian population is composed of many different ethnic
groups, to better analyze our findings, we looked for ethnic-
specific biases and compared our results to studies in neigh-
boring countries. In general, the Persian population is mainly
in central Iran, the Azeri are in the northwest, and the
Gilaki, Mazandarani, and Turkmen are in the north. Kurds
and Lurs are in the west region and Arabs are in the south
(Table VI).
We found the highest percentage of GJB2-related deafness
in the north and northwest regions of Iran (north, 38.3%;
northwest, 22.2%) (Table I, Fig. 1). This population is bounded
on the north by the Caspian Sea and remains relatively isolated
by mountains from other parts of Iran. Interestingly, in Turkey
the incidence of GJB2-related deafness is similar, reported in
one study to be 21.4% in 14 families with ARNSD. Identified
allele variants in the Turkish population included the 35delG
and 299–300delAT [Bayazit et al., 2003]. In another study
from Turkey of 60 families, GJB2 mutations were found in
31.7% of deaf probands, with the 35delG mutation accounting
for 73.6% of all GJB2 deafness-causing alleles [Uyguner et al.,
2003]. The frequency of the 35delG allele in the Turkish deaf
has been reported to range from 5% to 53% [Baris et al., 2001;
Tekin et al., 2003]. Taken together, these studies and our data
suggest that there is a gradual decrease in the frequency of the
TABLE VII. GJB2 Allele Variants by Ethnicity
Allele variant Turk Kurd
Gilaki and
Mazandarani Lur Persian Arab Baloochi Turkmen Iran
Mutation
delE120 4 (1.3%) 3 (1.4%) — 2 (3%) 4 (0.7%) — — — 13 (1%)
167delT — — — — 1 (0.17%) — 2 (3%) — 3 (0.2%)
R184P — 1 (0.5%) — — 2 (0.34%) — — — 3 (0.2%)
310del14 — — — — 2 (0.34%) — — — 2 (0.15%)
V27IþE114G 1 (0.3%) — — — 2 (0.34%) — — — 3 (0.2%)
R32H 1 (0.3%) 4 (1.9%) — — — — — — 5 (0.4%)
314del14 — — — 2 (3%) 2 (0.34%) — — — 4 (0.3%)
35delG 51 (17.3%) 21 (10.2%) 27 (37.5%) 5 (7.6%) 58 (9.8%) 5 (16.7%) — — 167 (12.6%)
IVS1þ 1G>A — 3 (1.4%) — — — — — — 3 (0.2%)
3170G>A 4 (1.3%) 2 (1%) 2 (2.8%) — 5 (0.84%) — — — 13 (1%)
R127H 1 (0.3%) 2 (1%) 1 (1.4%) — 5 (0.84%) — 2 (3%) — 11 (0.8%)
W24X 1 (0.3%) — 1 (1.4%) 1 (1.5%) 4 (0.7%) — 4 (6%) — 11 (0.8%)
R143W — — — — — — — — 1 (0.07%)
M93I — — — — — — 1 (1.5%) — 1 (0.07%)
E129K 1 (0.3%) — — — — — — — 1 (0.07%)
312del14 — — — — 4 (0.7%) — — — 4 (0.3%)
Novel
329delA — — — — 1 (0.17%) — — — 1 (0.07%)
363delC 1 (0.3%) — — — — — — — 1 (0.07%)
507insAACG — 1 (0.5%) — — — — — — 1 (0.07%)
Q80L 2 (0.7%) — — — — — — — 2 (0.15%)
Polymorphism
V27I 6 (2%) — — — 3 (0.5%) — — — 9 (0.7%)
I69I — — — — 1 (0.17%) — — — 1 (0.07%)
V52V — — — — — 1 (3.3%) — — 1 (0.07%)
V153I 4 (1.3%) 8 (4%) 3 (4.2%) 5 (7.6%) 12 (2%) — 4 (6%) — 36 (2.7%)
Total alleles
tested
294 206 72 66 592 30 66 2 1,328
TABLE VI. Ethnic Groups in Iran and Their
Percentage Distributions
Ethnic group Percent Percentage distribution
Persian 51 44.6
Azeri 24 22.1
Gilaki and Mazandarani 8 5.4
Kurd 7 15.5
Arab 3 2.3
Lur 2 5
Balooch 2 5
Turkmen 2 0.1
Other 1 —
Total 100 100
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35delG mutation and in GJB2-related deafness in general as
we move from the northwest to south and east through the
Persian Gulf countries (Table VII).
This observed northwest-to-southeast GJB2 deafness gra-
dient is further supported by data specific to southeast Iran
where the population shares close ethnic ties to neighboring
Pakistan. The incidence of GJB2-related deafness in these
regions is similar (Table I, Fig. 2). In southeast Iran, we found
that GJB2-related deafness accounted for 9.2% of the ARNSD
genetic load and in Pakistan, in a study of 27 families with
presumed ARNSD, only one family hadGJB2-related deafness
(3.7%) [Brown et al., 1996]. In the southern part of Iran, where
the population is mainly Arab, GJB2-related deafness was not
found. Studies of GJB2-related deafness in Arab populations
in Oman also have identified no deafness-causing muta-
tions and complete absence of the 35delG and 167delT
mutations [Simsek et al., 2001a,b].
The northwest-to-southeastGJB2 deafness gradient through
the Persian Gulf countries mirrors the south-to-north Euro-
pean gradient identified through a meta-analysis of European
countries [Gasparini et al., 2000; Lucotte and Mercier, 2001;
Van Laer et al., 2001; Rothrock et al., 2003], and reflects the
historical importance of southern Europe and the eastern
Mediterranean as regions of diversity through population
movement, wars, and migrations. Data from Greece, for
example, are consistent with this hypothesis, as GJB2-related
deafness accounts for one-third of ARNSD [Antoniadi et al.,
2000; Iliades et al., 2002].
Our data highlight the importance that clinicians and
geneticists must pay to the general pattern of GJB2-related
deafness across the world. It is important to be aware of the
diverse influences on ARNSD in discrete populations. These
differences will affect the relative mutation load specific genes
make to ARNSD in different countries.
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